Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ophthalmic Artery Resistance Index After Peribulbar Block with Epinephrine
NCT04153123Completed
- Sponsor
- Universidade Federal de Minas Gerais
- Start
- Dec 2013
- Primary completion
- May 2014
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Trial of epinephrine in cataract (2 arms), sponsored by Universidade Federal de Minas Gerais. Primary endpoint: Artery resistance index of ophthalmic artery at 10 months. Started Dec 2013; status: completed.
02
Drugs
epinephrine
03
Conditions
cataract
Beyond the preview
Go deeper on NCT04153123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04153123.